Exact Mass: 596.2388116000001
Exact Mass Matches: 596.2388116000001
Found 326 metabolites which its exact mass value is equals to given mass value 596.2388116000001
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Cannabisin B
Cannabisin B is a natural product found in Xylopia aethiopica and Cannabis sativa with data available. See also: Cannabis sativa subsp. indica top (part of).
Magnoline
Guattegaumerine
An aromatic ether resulting from oxidative dimerisation between the 4-hydroxy group of one molecule of (1R)-1-(4-hydroxybenzyl)-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-ol and the 3-position of the 4-hydroxybenzyl group of another.
Dipiperamide D
Dipiperamide D is an alkaloid from white pepper, Piper nigrum. Alkaloid from white pepper, Piper nigrum
Pipercyclobutanamide B
Pipercyclobutanamide B is found in herbs and spices. Pipercyclobutanamide B is an alkaloid from the fruit of Piper nigrum (pepper Alkaloid from the fruit of Piper nigrum (pepper). Pipercyclobutanamide B is found in herbs and spices.
Tetragastrin
Tetragastrin is the C-terminal tetrapeptide of gastrin. It is the smallest peptide fragment of gastrin which has the same physiological and pharmacological activity as gastrin. [HMDB] Tetragastrin is the C-terminal tetrapeptide of gastrin. It is the smallest peptide fragment of gastrin which has the same physiological and pharmacological activity as gastrin. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005755 - Gastrins Tetragastrin (Cholecystokinin tetrapeptide; CCK-4) is the C-terminal tetrapeptide of gastrin. Tetragastrin can stimulate gastric secretion[1]. Tetragastrin is a Cholecystokinin (CCK-4) receptor agonist[2]. Gastric mucosal protection[3]. Tetragastrin (Cholecystokinin tetrapeptide; CCK-4) is the C-terminal tetrapeptide of gastrin. Tetragastrin can stimulate gastric secretion[1]. Tetragastrin is a Cholecystokinin (CCK-4) receptor agonist[2]. Gastric mucosal protection[3].
Chlorin E6
Chlorin E6 (chlorin(e6)) is a photosensitizer used in photodynamic therapy. Photodynamic therapy (PDT) is a form of phototherapy using nontoxic light-sensitive compounds that are exposed selectively to light, whereupon they become toxic to targeted malignant and other diseased cells. PDT has proven ability to kill microbial cells including bacteria, fungi and viruses. PDT is popularly used in treating acne. It is used clinically to treat a wide range of medical conditions, including wet age-related macular degeneration and malignant cancers, and is recognised as a treatment strategy which is both minimally invasive and minimally toxic. A photosensitizer is a chemical compound that can be promoted to an excited state upon absorption light and undergo intersystem crossing with oxygen to produce singlet oxygen. This species rapidly attacks any organic compounds it encounters, thus being highly cytotoxic. A wide array of photosensitizers for PDT exist. They can be divided into porphyrins, chlorophylls and dyes. Some examples include aminolevulinic acid (ALA), Silicon Phthalocyanine Pc 4, m-tetrahydroxyphenylchlorin (mTHPC), and mono-L-aspartyl chlorin e6 (NPe6). (Wikipedia)
GDC-0834 Racemate
(7R,8R,8S)-4,4,9-trihydroxy-3,3,5,5-tetramethoxy-7,9-epoxylignan-7-one 9-O-beta-D-glucopyranoside|(7R,8R,8S)-aketrilignoside B
4-hydroxyphenyl beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranoside|4-hydroxyphenyl-beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranoside|p-Hydroxyphenyl-beta-gentiotriosid
(7S*,8R*,7S*,8R*)-4,4-dimethoxyhuazhongilexin 9-O-alpha-L-arabinopyranoside
gnetumontanin C 4a-O-beta-D-glucopyranoside|gnetumontanin D
3-hydroxy-4,5-dimethoxyphenyl 6-O-{(2E,4E)-5-[(1R,3S,5R,8S)-3,8-dihydroxy-1,5-dimethyl-6-oxabixyclo[3.2.1.]oct-8-yl]-3-methyl-1-oxopenta-2,4-dien-1-yl}-alpha-L-glucopyranoside|thorelinin
Thollosidsaeure-methylester|Thollosidsaeuremethylester; 3beta-(alpha-L-Rhamnosido-(1,5))-sarmentosigenin-A-saeuremethylester; 3beta-(alpha-L-Rhamnosido-(1,5))-5,11alpha,14beta-trihydroxy-5beta-cardenolid-19-saeuremethylester|Thollosidsaeuremethylester; 3beta--sarmentosigenin-A-saeuremethylester; 3beta--5,11alpha,14beta-trihydroxy-5beta-cardenolid-19-saeuremethylester
(+)-4-O-methyllyoniresin-4-yl beta-D-glucopyranoside
Hexa-Me ether-(R)-2,4,7-Trihydroxy-3-(2,4,7-trihydroxyisoflavan-6-yl)flav-2-ene
3,7,15-O-triacetyl-5-O-benzoyl-13,17-oxy-14-oxopremyrsinol
(3R)-4-[6-[(2S,4aS,5aR,9R,9aR,10aR)-2,9-dimethyl-3-oxo-4,4a,5a,6,7,9,9a,10a-octahydrodipyrano[4,2-a:4,3-e][1,4]dioxin-7-yl]-1,5-dihydroxy-9,10-dioxoanthracen-2-yl]-3-hydroxy-3-methylbutanoic acid
C33H40O10_1H-Cyclopentacyclododecene-4,10(2H,5H)-dione, 3a,9,13-tris(acetyloxy)-1-(benzoyloxy)-3,3a,8,9,13,13a-hexahydro-2,5,8,8,12-pentamethyl-, (6E,11E)
Cys Arg Arg Tyr
Cys Arg Tyr Arg
Cys Tyr Arg Arg
Asp His Tyr Tyr
Asp Asn Trp Tyr
Asp Asn Tyr Trp
Asp Trp Asn Tyr
Asp Trp Tyr Asn
Asp Tyr His Tyr
Asp Tyr Asn Trp
Asp Tyr Trp Asn
Asp Tyr Tyr His
Phe Phe Phe His
Phe Phe His Phe
Phe His Phe Phe
Phe His Met Tyr
Phe His Tyr Met
Phe Met His Tyr
Phe Met Asn Trp
Phe Met Trp Asn
Phe Met Tyr His
Phe Asn Met Trp
Phe Asn Trp Met
Phe Trp Met Asn
Phe Trp Asn Met
Phe Tyr His Met
Phe Tyr Met His
His Asp Tyr Tyr
His Phe Phe Phe
His Phe Met Tyr
His Phe Tyr Met
His Met Phe Tyr
His Met Tyr Phe
His Tyr Asp Tyr
His Tyr Phe Met
His Tyr Met Phe
His Tyr Tyr Asp
Met Phe His Tyr
Met Phe Asn Trp
Met Phe Trp Asn
Met Phe Tyr His
Met His Phe Tyr
Met His Tyr Phe
Met Asn Phe Trp
Met Asn Trp Phe
Met Gln Arg Tyr
C25H40N8O7S (596.2740530000001)
Met Gln Tyr Arg
C25H40N8O7S (596.2740530000001)
Met Arg Gln Tyr
C25H40N8O7S (596.2740530000001)
Met Arg Tyr Gln
C25H40N8O7S (596.2740530000001)
Met Trp Phe Asn
Met Trp Asn Phe
Met Tyr Phe His
Met Tyr His Phe
Met Tyr Gln Arg
C25H40N8O7S (596.2740530000001)
Met Tyr Arg Gln
C25H40N8O7S (596.2740530000001)
Asn Asp Trp Tyr
Asn Asp Tyr Trp
Asn Phe Met Trp
Asn Phe Trp Met
Asn Met Phe Trp
Asn Met Trp Phe
Asn Trp Asp Tyr
Asn Trp Phe Met
Asn Trp Met Phe
Asn Trp Tyr Asp
Asn Tyr Asp Trp
Asn Tyr Trp Asp
Gln Met Arg Tyr
C25H40N8O7S (596.2740530000001)
Gln Met Tyr Arg
C25H40N8O7S (596.2740530000001)
Gln Arg Met Tyr
C25H40N8O7S (596.2740530000001)
Gln Arg Tyr Met
C25H40N8O7S (596.2740530000001)
Gln Thr Trp Tyr
Gln Thr Tyr Trp
Gln Trp Thr Tyr
Gln Trp Tyr Thr
Gln Tyr Met Arg
C25H40N8O7S (596.2740530000001)
Gln Tyr Arg Met
C25H40N8O7S (596.2740530000001)
Gln Tyr Thr Trp
Gln Tyr Trp Thr
Arg Cys Arg Tyr
Arg Cys Tyr Arg
Arg Met Gln Tyr
C25H40N8O7S (596.2740530000001)
Arg Met Tyr Gln
C25H40N8O7S (596.2740530000001)
Arg Gln Met Tyr
C25H40N8O7S (596.2740530000001)
Arg Gln Tyr Met
C25H40N8O7S (596.2740530000001)
Arg Arg Cys Tyr
Arg Arg Tyr Cys
Arg Tyr Cys Arg
Arg Tyr Met Gln
C25H40N8O7S (596.2740530000001)
Arg Tyr Gln Met
C25H40N8O7S (596.2740530000001)
Arg Tyr Arg Cys
Thr Gln Trp Tyr
Thr Gln Tyr Trp
Thr Trp Gln Tyr
Thr Trp Tyr Gln
Thr Tyr Gln Trp
Thr Tyr Trp Gln
Trp Asp Asn Tyr
Trp Asp Tyr Asn
Trp Phe Met Asn
Trp Phe Asn Met
Trp Met Phe Asn
Trp Met Asn Phe
Trp Asn Asp Tyr
Trp Asn Phe Met
Trp Asn Met Phe
Trp Asn Tyr Asp
Trp Gln Thr Tyr
Trp Gln Tyr Thr
Trp Thr Gln Tyr
Trp Thr Tyr Gln
Trp Tyr Asp Asn
Trp Tyr Asn Asp
Trp Tyr Gln Thr
Trp Tyr Thr Gln
Tyr Cys Arg Arg
Tyr Asp His Tyr
Tyr Asp Asn Trp
Tyr Asp Trp Asn
Tyr Asp Tyr His
Tyr Phe His Met
Tyr Phe Met His
Tyr His Asp Tyr
Tyr His Phe Met
Tyr His Met Phe
Tyr His Tyr Asp
Tyr Met Phe His
Tyr Met His Phe
Tyr Met Gln Arg
C25H40N8O7S (596.2740530000001)
Tyr Met Arg Gln
C25H40N8O7S (596.2740530000001)
Tyr Asn Asp Trp
Tyr Asn Trp Asp
Tyr Gln Met Arg
C25H40N8O7S (596.2740530000001)
Tyr Gln Arg Met
C25H40N8O7S (596.2740530000001)
Tyr Gln Thr Trp
Tyr Gln Trp Thr
Tyr Arg Cys Arg
Tyr Arg Met Gln
C25H40N8O7S (596.2740530000001)
Tyr Arg Gln Met
C25H40N8O7S (596.2740530000001)
Tyr Arg Arg Cys
Tyr Thr Gln Trp
Tyr Thr Trp Gln
Tyr Trp Asp Asn
Tyr Trp Asn Asp
Tyr Trp Gln Thr
Tyr Trp Thr Gln
Tyr Tyr Asp His
Tyr Tyr His Asp
CCK-4
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005755 - Gastrins Tetragastrin (Cholecystokinin tetrapeptide; CCK-4) is the C-terminal tetrapeptide of gastrin. Tetragastrin can stimulate gastric secretion[1]. Tetragastrin is a Cholecystokinin (CCK-4) receptor agonist[2]. Gastric mucosal protection[3]. Tetragastrin (Cholecystokinin tetrapeptide; CCK-4) is the C-terminal tetrapeptide of gastrin. Tetragastrin can stimulate gastric secretion[1]. Tetragastrin is a Cholecystokinin (CCK-4) receptor agonist[2]. Gastric mucosal protection[3].
Pipercyclobutanamide B
Dipiperamide D
Chlorin E6
D011838 - Radiation-Sensitizing Agents
Trimetaphan camsylate
C32H40N2O5S2 (596.2378510000001)
D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
Phenolphthalein monophosphate dicyclohexylammonium salt
N-[5-(1,1-DIMETHYLETHYL)-3-ISOXAZOLYL]-N-[4-[7-[2-(4-MORPHOLINYL)ETHOXY]IMIDAZO[2,1-B]BENZOTHIAZOL-2-YL]PHENYL]UREA HYDROCHLORIDE
4-Methoxyphenyl 2,4,6-tris-O-(phenylmethyl)-3-O-2-propen-1-yl-beta-D-galactopyranoside
N-[3,5-bis(trifluoroMethyl)phenyl]-N-[(9R)-10,11-dihydro-6-Methoxycinchonan-9-yl]- Thiourea
H-Tyr-Arg-Gly-Asp-Ser-OH trifluoroacetate salt
YRGDS Fibronectin Fragment is a fibronectin fragment, an adhesion peptide that displays strong binding affinity to thrombin-stimulated platelets[1].
(r,r)-ethylenebis-(4,5,6,7-tetrahydro-1-indenyl)-titanium(iv)-(r)-(1,1-binaphthyl-2)
C40H36O2Ti (596.2194625999999)
(2S)-3-(4-(4-Carbamoylpiperidine-1-carbonyl)oxyphenyl)-2-(((2S)-4-methyl-2-((2-(2-methylphenoxy)acetyl)amino)pentanoyl)amino)propanoic acid
C31H40N4O8 (596.2846000000001)
haematoporphyrin IX
D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents > D006415 - Hematoporphyrins D003879 - Dermatologic Agents
3-[(17S,18R)-18-(2-carboxyethyl)-7,12-bis(ethenyl)-17,18-dihydroxy-3,8,13,17-tetramethyl-22,23-dihydroporphyrin-2-yl]propanoic acid
3-[(17R,18R)-18-(2-carboxyethyl)-7,12-bis(ethenyl)-17,18-dihydroxy-3,8,13,17-tetramethyl-22,23-dihydroporphyrin-2-yl]propanoic acid
Trimethaphan Camsylate
C32H40N2O5S2 (596.2378510000001)
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C66886 - Nicotinic Antagonist C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
1-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)sulfonyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-phenylurea
1-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)sulfonyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-phenylurea
[(6E,11E)-3a,9,13-triacetyloxy-2,5,8,8,12-pentamethyl-4,10-dioxo-2,3,5,9,13,13a-hexahydro-1H-cyclopenta[12]annulen-1-yl] benzoate
[(4R,5R)-4-[[2-(azidomethyl)phenyl]methyl]-5-(2-azidophenyl)-2-[4-(3-hydroxypropoxy)phenyl]-5H-oxazol-4-yl]-(4-morpholinyl)methanone
C31H32N8O5 (596.2495541999999)
1-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)sulfonyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-phenylurea
1-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)sulfonyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-phenylurea
1-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)sulfonyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-phenylurea
1-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)sulfonyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-phenylurea
1-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)sulfonyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-phenylurea
(4R,7S,8R)-N-(3,5-dimethyl-4-isoxazolyl)-14-[[(3-fluoroanilino)-oxomethyl]amino]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide
1-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)sulfonyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-phenylurea
(4S,7R,8R)-N-(3,5-dimethyl-1,2-oxazol-4-yl)-14-[(3-fluorophenyl)carbamoylamino]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide
(4S,7S,8R)-N-(3,5-dimethyl-1,2-oxazol-4-yl)-14-[(3-fluorophenyl)carbamoylamino]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide
(4S,7S,8S)-N-(3,5-dimethyl-1,2-oxazol-4-yl)-14-[(3-fluorophenyl)carbamoylamino]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide
(4R,7S,8S)-N-(3,5-dimethyl-4-isoxazolyl)-14-[[(3-fluoroanilino)-oxomethyl]amino]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide
(4R,7R,8S)-N-(3,5-dimethyl-4-isoxazolyl)-14-[[(3-fluoroanilino)-oxomethyl]amino]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide
(4R,7R,8R)-N-(3,5-dimethyl-4-isoxazolyl)-14-[[(3-fluoroanilino)-oxomethyl]amino]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide
(4S,7R,8S)-N-(3,5-dimethyl-4-isoxazolyl)-14-[[(3-fluoroanilino)-oxomethyl]amino]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide
3-[(17S,18R)-18-(2-carboxyethyl)-8,13-bis(ethenyl)-17,18-dihydroxy-3,7,12,17-tetramethyl-22,23-dihydroporphyrin-2-yl]propanoic acid
3-[(17R,18R)-18-(2-carboxyethyl)-8,13-bis(ethenyl)-17,18-dihydroxy-3,7,12,17-tetramethyl-22,23-dihydroporphyrin-2-yl]propanoic acid
[(11Z)-3a,9,13-triacetyloxy-2,5,8,8,12-pentamethyl-4,10-dioxo-2,3,5,9,13,13a-hexahydro-1H-cyclopenta[12]annulen-1-yl] benzoate
Tetragastrin
A tetrapeptide composed of L-tryptophan, L-methione, L-aspartic acid and L-phenylalaninamide residues joined in sequence.
(1s,2r,3ar,10s,11s,13as)-3a,10,11-tris(acetyloxy)-2,5,8,8,12-pentamethyl-4,9-dioxo-1h,2h,3h,7h,10h,11h,13ah-cyclopenta[12]annulen-1-yl benzoate
(5ar,11s,11ar,12r)-1,3,4,6,8,9-hexamethoxy-11-phenyl-12-[(1e)-2-phenylethenyl]-5a,11,11a,12-tetrahydro-5,10-dioxatetraphene
methyl (2e)-2-(n-hydroxyimino)-3-{7-[(1e)-2-{3-[(2e)-2-(hydroxyimino)-3-methoxy-3-oxopropyl]-11-methyl-9-(2-methylprop-1-en-1-yl)-1-azatricyclo[6.3.1.0⁴,¹²]dodeca-2,4,6,8(12)-tetraen-11-yl}ethenyl]-1h-indol-3-yl}propanoate
(1r,4ar,5r,6r,7s,8r,8ar)-7-(acetyloxy)-8a-[(acetyloxy)methyl]-6-hydroxy-5,6-dimethyl-5-[2-(5-oxo-2h-furan-3-yl)ethyl]-hexahydrospiro[naphthalene-1,2'-oxiran]-8-yl (2e)-3-phenylprop-2-enoate
(8r,9r,10r,11s)-11-(acetyloxy)-10,16-dihydroxy-3,4,5,14,15-pentamethoxy-9,10-dimethyltricyclo[10.4.0.0²,⁷]hexadeca-1(12),2(7),3,5,13,15-hexaen-8-yl benzoate
3a,10,13-tris(acetyloxy)-2,5,8,8-tetramethyl-12-methylidene-4,9-dioxo-1h,2h,3h,5h,10h,11h,13h,13ah-cyclopenta[12]annulen-1-yl benzoate
(1s,2s,3e)-1-(3,4-dihydroxyphenyl)-5,6-dihydroxy-n-[2-(4-hydroxyphenyl)ethyl]-3-({[2-(4-hydroxyphenyl)ethyl]-c-hydroxycarbonimidoyl}methylidene)-1,2-dihydroindene-2-carboximidic acid
1-[(1s,2s,5s,6r)-5,6-bis[(1e)-2-(2h-1,3-benzodioxol-5-yl)ethenyl]-2-(piperidine-1-carbonyl)cyclohex-3-ene-1-carbonyl]piperidine
1-{[4-(2-hydroxy-5-{[(1s)-7-hydroxy-6-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-1-yl]methyl}phenoxy)phenyl]methyl}-6-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-7-ol
3a,10,11-tris(acetyloxy)-2,5,8,8,12-pentamethyl-4,9-dioxo-1h,2h,3h,7h,10h,11h,13ah-cyclopenta[12]annulen-1-yl benzoate
2-{4-[4-hydroxy-4-(4-hydroxy-3,5-dimethoxyphenyl)-tetrahydro-1h-furo[3,4-c]furan-1-yl]-2,6-dimethoxyphenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2r,3r,4s,5s,6r)-2-{[(2r,3s,4s)-4-(4-hydroxy-3,5-dimethoxybenzoyl)-2-(4-hydroxy-3,5-dimethoxyphenyl)oxolan-3-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(1r,3r,4r,5r,7s,8s,9r,10e,12s,13s,14s)-4,9,13-tris(acetyloxy)-3,6,6,10,14-pentamethyl-2-oxo-16-oxatetracyclo[10.3.1.0¹,¹².0⁵,⁷]hexadec-10-en-8-yl benzoate
1-[2,4-bis({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})phenyl]-3-(4-methoxyphenyl)propan-1-one
methyl 2,12,14,16-tetrakis(acetyloxy)-3-hydroxy-4,13,17-trimethyl-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-ene-9-carboxylate
5,31-dimethoxy-11,26-dimethyl-2,18-dioxa-11,26-diazaheptacyclo[23.6.2.2¹⁴,¹⁷.1¹⁹,²³.0³,⁸.0⁷,¹².0²⁹,³³]hexatriaconta-1(32),3(8),4,6,14,16,19(34),20,22,30,35-undecaene-4,20-diol
(2r)-2-{[(2s)-2-{[(2s,3s,4r)-2-amino-1,4-dihydroxy-4-(5-hydroxypyridin-2-yl)-3-methylbutylidene]amino}-2-[(2s,3s,4r,5s)-5-(4-formyl-2-hydroxyimidazol-1-yl)-3,4-dihydroxyoxolan-2-yl]-1-hydroxyethylidene]amino}-4-hydroxybutanoic acid
C24H32N6O12 (596.2078111999999)